630 Fifth Avenue
Suite 2260
New York, NY 10020
United States
801-214-7800
https://www.myrexis.com
Sector(s): Financial Services
Industry: Shell Companies
Full Time Employees: 1
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Jonathan M. Couchman | Chairman, CEO, President, CFO & Principal Accounting Officer | 1 | N/A | 1970 |
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
Myrexis, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.